BTC $81,802.27 -1.85%
ETH $2,400.26 -2.47%
BNB $732.90 -1.82%
XRP $1.33 -2.05%
SOL $104.42 -2.21%
TRX $0.3304 -0.07%
DOGE $0.0792 -3.47%
ADA $0.2169 -4.03%
BCH $276.13 -3.90%
LINK $12.07 -2.57%
HYPE $78.48 -3.49%
AAVE $147.22 -5.87%
SUI $0.9870 -4.36%
XLM $0.1779 -3.75%
ZEC $1,253.35 -2.56%
AAPL $343.43 +1.40%
AMZN $257.23 -2.43%
GOOGL $327.47 -2.81%
MSFT $528.12 -0.34%
META $679.02 -1.80%
NVDA $217.58 -1.82%
TSLA $372.62 -1.76%
SNDK $1,325.41 -5.95%
INTC $88.81 -5.56%
SPCX $155.68 -1.84%
MU $885.55 -4.04%
AMD $528.66 -3.14%
BTC $81,802.27 -1.85%
ETH $2,400.26 -2.47%
BNB $732.90 -1.82%
XRP $1.33 -2.05%
SOL $104.42 -2.21%
TRX $0.3304 -0.07%
DOGE $0.0792 -3.47%
ADA $0.2169 -4.03%
BCH $276.13 -3.90%
LINK $12.07 -2.57%
HYPE $78.48 -3.49%
AAVE $147.22 -5.87%
SUI $0.9870 -4.36%
XLM $0.1779 -3.75%
ZEC $1,253.35 -2.56%
AAPL $343.43 +1.40%
AMZN $257.23 -2.43%
GOOGL $327.47 -2.81%
MSFT $528.12 -0.34%
META $679.02 -1.80%
NVDA $217.58 -1.82%
TSLA $372.62 -1.76%
SNDK $1,325.41 -5.95%
INTC $88.81 -5.56%
SPCX $155.68 -1.84%
MU $885.55 -4.04%
AMD $528.66 -3.14%

The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

app_icon
ChainCatcher Building the Web3 world with innovations.